Preclinical AD is a condition in which cognitive function remains normal, with the presence of biomarkers indicative of disease, such as Aβ plaques detected by PiB or 18F-florbetapir (AV45) radioligand during PET imaging and CSF assays of Aβ42, Aβ40 and tau [5]. Here, MAPT is linked to Alzheimer disease.